Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Cristina de Guzman Strong is active.

Publication


Featured researches published by Cristina de Guzman Strong.


The Journal of Allergy and Clinical Immunology | 2015

The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization

Shinji Noda; Mayte Suárez-Fariñas; Benjamin Ungar; Soo Jung Kim; Cristina de Guzman Strong; Hui Xu; Xiangyu Peng; Yeriel Estrada; Saeko Nakajima; Tetsuya Honda; Jung U Shin; Hemin Lee; James G. Krueger; Kwang Hoon Lee; Kenji Kabashima; Emma Guttman-Yassky

BACKGROUND Atopic dermatitis (AD) shows very high prevalence in Asia, with a large unmet need for effective therapeutics. Direct comparisons between European American (EA) and Asian patients with AD are unavailable, but earlier blood studies detected increased IL-17(+)-producing cell counts in Asian patients with AD. OBJECTIVE We sought to characterize the Asian AD skin phenotype and compare it with the EA AD skin phenotype. METHODS We performed genomic profiling (real-time PCR) and immunohistochemistry on lesional and nonlesional biopsy specimens from 52 patients with AD (25 EAs and 27 Asians), 10 patients with psoriasis (all EAs), and 27 healthy subjects (12 EAs and 15 Asians). RESULTS Although disease severity/SCORAD scores were similar between the AD groups (58.0 vs 56.7, P = .77), greater acanthosis, higher Ki67 counts, and frequent parakeratosis were characteristics of lesional epidermis from Asian patients with AD (P < .05). Most (24/27) Asian patients had high IgE levels. A principal component analysis using real-time PCR data clustered the Asian AD phenotype between the EA AD and psoriasis phenotypes. TH2 skewing characterized both Asian and EA patients with AD but not patients with psoriasis. Significantly higher TH17 and TH22 (IL17A, IL19, and S100A12 in lesional and IL-22 in nonlesional skin; P < .05) and lower TH1/interferon (CXCL9, CXCL10, MX1, and IFNG in nonlesional skin; P < .05) gene induction typified AD skin in Asian patients. CONCLUSION The Asian AD phenotype presents (even in the presence of increased IgE levels) a blended phenotype between that of EA patients with AD and those with psoriasis, including increased hyperplasia, parakeratosis, higher TH17 activation, and a strong TH2 component. The relative pathogenic contributions of the TH17 and TH2 axes in creating the Asian AD phenotype need to be tested in future clinical trials with appropriate targeted therapeutics.


Proceedings of the National Academy of Sciences of the United States of America | 2014

Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs

Scot J. Matkovich; John R. Edwards; Tiffani C. Grossenheider; Cristina de Guzman Strong; Gerald W. Dorn

Significance The role of noncoding RNAs in mammalian biology is of great interest, especially since the Encyclopedia of DNA Elements results were published. We and others have studied microRNAs in the heart, but little is known about their larger cousins, long noncoding RNAs (lncRNAs). Here, we used genome-wide sequencing and improved bioinformatics to quantify lncRNA expression in mouse hearts, define a subset of cardiac-specific lncRNAs, and measure dynamic lncRNA regulation during the transition between embryo and adult, and in the adult heart after experimental pressure overload (a model resembling human hypertensive cardiomyopathy). We linked specific regulated lncRNAs to cardiac-expressed mRNAs that they target and, through network analyses, discovered a broader role of regulated cardiac lncRNAs as modulators of key cardiac transcriptional pathways. The vast majority of mammalian DNA does not encode for proteins but instead is transcribed into noncoding (nc)RNAs having diverse regulatory functions. The poorly characterized subclass of long ncRNAs (lncRNAs) can epigenetically regulate protein-coding genes by interacting locally in cis or distally in trans. A few reports have implicated specific lncRNAs in cardiac development or failure, but precise details of lncRNAs expressed in hearts and how their expression may be altered during embryonic heart development or by adult heart disease is unknown. Using comprehensive quantitative RNA sequencing data from mouse hearts, livers, and skin cells, we identified 321 lncRNAs present in the heart, 117 of which exhibit a cardiac-enriched pattern of expression. By comparing lncRNA profiles of normal embryonic (∼E14), normal adult, and hypertrophied adult hearts, we defined a distinct fetal lncRNA abundance signature that includes 157 lncRNAs differentially expressed compared with adults (fold-change ≥ 50%, false discovery rate = 0.02) and that was only poorly recapitulated in hypertrophied hearts (17 differentially expressed lncRNAs; 13 of these observed in embryonic hearts). Analysis of protein-coding mRNAs from the same samples identified 22 concordantly and 11 reciprocally regulated mRNAs within 10 kb of dynamically expressed lncRNAs, and reciprocal relationships of lncRNA and mRNA levels were validated for the Mccc1 and Relb genes using in vitro lncRNA knockdown in C2C12 cells. Network analysis suggested a central role for lncRNAs in modulating NFκB- and CREB1-regulated genes during embryonic heart growth and identified multiple mRNAs within these pathways that are also regulated, but independently of lncRNAs.


The Journal of Allergy and Clinical Immunology | 2014

Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.

Saakshi Khattri; Avner Shemer; Mariya Rozenblit; Nikhil Dhingra; Tali Czarnowicki; Robert Finney; Patricia Gilleaudeau; Mary Sullivan-Whalen; Xiuzhong Zheng; Hui Xu; Irma Cardinale; Cristina de Guzman Strong; Juana Gonzalez; Mayte Suárez-Fariñas; Jim G. Krueger; Emma Guttman-Yassky

BACKGROUND Atopic dermatitis (AD) is the most common inflammatory disease. Evolving disease models link changes in epidermal growth and differentiation to T(H)2/T(H)22 cytokine activation. However, these models have not been tested by in vivo suppression of T-cell cytokines. Cyclosporine (CsA) is an immunosuppressant that is highly effective for severe disease, but its mechanism in AD skin lesions has not been studied. OBJECTIVE We sought to establish the ability of a systemic immunosuppressant to modulate immune and epidermal alterations that form the pathogenic disease phenotype and to correlate changes with clinical improvement. METHODS CsAs effects on AD skin pathology were evaluated by using gene expression and immunohistochemistry studies in baseline, week 2, and week 12 lesional and nonlesional biopsy specimens from 19 patients treated with 5 mg/kg/d CsA for 12 weeks. RESULTS After 2 and 12 weeks of treatment, we observed significant reductions of 51% and 72%, respectively, in SCORAD scores. Clinical improvements were associated with significant gene expression changes in lesional but also nonlesional skin, particularly reductions in levels of T(H)2-, T(H)22-, and some T(H)17-related molecules (ie, IL-13, IL-22, CCL17, S100As, and elafin/peptidase inhibitor 3), and modulation of epidermal hyperplasia and differentiation measures. CONCLUSIONS This is the first study that establishes a relationship between cytokine activation and molecular epidermal alterations, as well as correlations between disease biomarkers in the skin and clinical improvement. The reversal of the molecular phenotype with CsA and the associated biomarkers can serve as a reference for the successful modulation of tissue inflammation with specific immune antagonists in future studies, contributing to the understanding of the specific cytokines involved in epidermal pathology.


Human Molecular Genetics | 2010

A milieu of regulatory elements in the epidermal differentiation complex syntenic block: implications for atopic dermatitis and psoriasis

Cristina de Guzman Strong; Sean Conlan; Clayton Deming; Jun Cheng; Karen E. Sears; Julia A. Segre

Two common inflammatory skin disorders with impaired barrier, atopic dermatitis (AD) and psoriasis, share distinct genetic linkage to the Epidermal Differentiation Complex (EDC) locus on 1q21. The EDC is comprised of tandemly arrayed gene families encoding proteins involved in skin cell differentiation. Discovery of semi-dominant mutations in filaggrin (FLG) associated with AD and a copy number variation within the LCE genes associated with psoriasis provide compelling evidence for the role of EDC genes in the pathogenesis of these diseases. To date, little is known about the potentially complex regulatory landscape within the EDC. Here, we report a computational approach to identify conserved non-coding elements (CNEs) in the EDC queried for regulatory function. Coordinate expression of EDC genes during mouse embryonic skin development and a striking degree of synteny and linearity in the EDC locus across a wide range of mammalian (placental and marsupial) genomes suggests an evolutionary conserved regulatory milieu in the EDC. CNEs identified by comparative genomics exhibit dynamic regulatory activity (enhancer or repressor) in differentiating or proliferating conditions. We further demonstrate epidermal-specific, developmental in vivo enhancer activities (DNaseI and transgenic mouse assays) in CNEs, including one within the psoriasis-associated deletion, LCE3C_LCE3B-del. Together, our multidisciplinary study features a network of regulatory elements coordinating developmental EDC gene expression as an unexplored resource for genetic variants in skin diseases.


Genes & Development | 2013

Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation

Jasbir S. Dalal; Jee Hoon Roh; Susan E. Maloney; Afua A. Akuffo; Samir Shah; Han Yuan; Brie Wamsley; Wendell B. Jones; Cristina de Guzman Strong; Paul A. Gray; David M. Holtzman; Nathaniel Heintz; Joseph D. Dougherty

Hypocretin (orexin; Hcrt)-containing neurons of the hypothalamus are essential for the normal regulation of sleep and wake behaviors and have been implicated in feeding, anxiety, depression, and reward. The absence of these neurons causes narcolepsy in humans and model organisms. However, little is known about the molecular phenotype of these cells; previous attempts at comprehensive profiling had only limited sensitivity or were inaccurate. We generated a Hcrt translating ribosome affinity purification (bacTRAP) line for comprehensive translational profiling of all ribosome-bound transcripts in these neurons in vivo. From this profile, we identified >6000 transcripts detectably expressed above background and 188 transcripts that are highly enriched in these neurons, including all known markers of the cells. Blinded analysis of in situ hybridization databases suggests that ~60% of these are expressed in a Hcrt marker-like pattern. Fifteen of these were confirmed with double labeling and microscopy, including the transcription factor Lhx9. Ablation of this gene results in a >30% loss specifically of Hcrt neurons, without a general disruption of hypothalamic development. Polysomnography and activity monitoring revealed a profound hypersomnolence in these mice. These data provide an in-depth and accurate profile of Hcrt neuron gene expression and suggest that Lhx9 may be important for specification or survival of a subset of these cells.


Journal of Investigative Dermatology | 2014

Regulation of the dynamic chromatin architecture of the epidermal differentiation complex is mediated by a c-Jun/AP-1-modulated enhancer.

Inez Y. Oh; Danielle M. Albea; Z. Goodwin; A. Quiggle; Breeana P. Baker; Ann M. Guggisberg; Jessica H. Geahlen; Grace Kroner; Cristina de Guzman Strong

The Epidermal Differentiation Complex (EDC) locus comprises a syntenic and linear cluster of genes whose concomitant expression is a hallmark feature of differentiation in the developing skin epidermis. Many of the EDC proteins are cross-linked together to form the cornified envelope, an essential and discrete unit of the mammalian skin barrier. The mechanism underlying coordinate transcriptional activation of the EDC is unknown. Within the human EDC, we identified an epidermal-specific regulatory enhancer, 923, that responded to the developmental and spatio-temporal cues at the onset of epidermal differentiation in the mouse embryo. Comparative chromosomal conformation capture (3C) assays in proliferating and differentiated primary mouse keratinocytes revealed multiple chromatin interactions that were physiologically sensitive between the 923 enhancer and EDC gene promoters and thus depict the dynamic, chromatin topology of the EDC. We elucidate a mechanistic link between c-Jun/AP-1 and 923, whereby AP-1 and 923-mediated EDC chromatin remodeling is required for functional EDC gene activation. Thus, we identify a critical enhancer/transcription factor axis governing the dynamic regulation of the EDC chromatin architecture and gene expression and provide a framework for future studies towards understanding gene regulation in cutaneous diseases.


Journal of Investigative Dermatology | 2012

Preparing the next generation in academic medicine: recruiting and retaining the best.

Cristina de Guzman Strong; Lynn A. Cornelius

In many ways, we are living and working in an unprecedented time in academic medicine. New technologies, scientific discovery, unparalleled availability of medical information and knowledge are currently paired with increasing (albeit slow) gender, cultural, and now generational diversity of the faculty. To prepare the next generation, we must simultaneously be the student and the teacher. As the student, our charge is to understand the current medical and academic environs and recognize the attributes, experiences, and expectations that each generational cohort brings to medicine. As the teacher, we must identify, extract, and communicate the tenets that remain constants for success in academic medicine today and reject those that are no longer relevant. Throughout the years, the basic motivation that drives success has remained constant while the individuals (the players), the environment, and the definition of success in academics have become more varied.


Nature | 2018

Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis

Monika Bambouskova; Laurent Gorvel; Vicky Lampropoulou; Alexey Sergushichev; Ekaterina Loginicheva; Kendall Johnson; Daniel Korenfeld; Mary Elizabeth Mathyer; Hyeryun Kim; Li-Hao Huang; Dustin Duncan; Howard Bregman; Abdurrahman Keskin; Andrea Santeford; Rajendra S. Apte; Raghav Sehgal; Britney Johnson; Gaya K. Amarasinghe; Miguel P. Soares; Takashi Satoh; Shizuo Akira; Tsonwin Hai; Cristina de Guzman Strong; Karine Auclair; Thomas P. Roddy; Scott A. Biller; Marko Jovanovic; Eynav Klechevsky; Kelly M. Stewart; Gwendalyn J. Randolph

Metabolic regulation has been recognized as a powerful principle guiding immune responses. Inflammatory macrophages undergo extensive metabolic rewiring1 marked by the production of substantial amounts of itaconate, which has recently been described as an immunoregulatory metabolite2. Itaconate and its membrane-permeable derivative dimethyl itaconate (DI) selectively inhibit a subset of cytokines2, including IL-6 and IL-12 but not TNF. The major effects of itaconate on cellular metabolism during macrophage activation have been attributed to the inhibition of succinate dehydrogenase2,3, yet this inhibition alone is not sufficient to account for the pronounced immunoregulatory effects observed in the case of DI. Furthermore, the regulatory pathway responsible for such selective effects of itaconate and DI on the inflammatory program has not been defined. Here we show that itaconate and DI induce electrophilic stress, react with glutathione and subsequently induce both Nrf2 (also known as NFE2L2)-dependent and -independent responses. We find that electrophilic stress can selectively regulate secondary, but not primary, transcriptional responses to toll-like receptor stimulation via inhibition of IκBζ protein induction. The regulation of IκBζ is independent of Nrf2, and we identify ATF3 as its key mediator. The inhibitory effect is conserved across species and cell types, and the in vivo administration of DI can ameliorate IL-17–IκBζ-driven skin pathology in a mouse model of psoriasis, highlighting the therapeutic potential of this regulatory pathway. Our results demonstrate that targeting the DI–IκBζ regulatory axis could be an important new strategy for the treatment of IL-17–IκBζ-mediated autoimmune diseases.The immunoregulatory metabolite itaconate and its dimethyl derivative induce electrophilic stress and react with glutathione to induce both Nrf2-dependent and Nrf2-independent responses, resulting in AF3-mediated inhibition of the inflammation-related protein IκBζ.


JAMA Dermatology | 2015

Low filaggrin monomer repeats in African American pediatric patients with moderate to severe atopic dermatitis.

A. Quiggle; Z. Goodwin; Twinkal R. Marfatia; Monique G. Kumar; Heather M. Ciliberto; Susan J. Bayliss; Cristina de Guzman Strong

The severity of atopic dermatitis (AD) and intragenic filaggrin (FLG; OMIM 135940) copy number variant (CNV) genotypes were assessed in African American pediatric patients, a health disparities group that is disproportionately affected with AD.1


Journal of Investigative Dermatology | 2017

The Molecular Revolution in Cutaneous Biology: EDC and Locus Control

Inez Y. Oh; Cristina de Guzman Strong

The epidermal differentiation complex (EDC) locus consists of a cluster of genes important for the terminal differentiation of the epidermis. While early studies identified the functional importance of individual EDC genes, the recognition of the EDC genes as a cluster with its shared biology, homology, and physical linkage was pivotal to later studies that investigated the transcriptional regulation of the locus. Evolutionary conservation of the EDC and the transcriptional activation during epidermal differentiation suggested a cis-regulatory mechanism via conserved noncoding elements or enhancers. This line of pursuit led to the identification of CNE 923, an epidermal-specific enhancer that was found to mediate chromatin remodeling of the EDC in an AP-1 dependent manner. These genomic studies, as well as the advent of high-throughput sequencing and genome engineering techniques, have paved the way for future investigation into enhancer-mediated regulatory networks in cutaneous biology.

Collaboration


Dive into the Cristina de Guzman Strong's collaboration.

Top Co-Authors

Avatar

Emma Guttman-Yassky

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

Mayte Suárez-Fariñas

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hui Xu

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

Inez Y. Oh

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Julia K Gittler

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Z. Goodwin

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

A. Quiggle

Washington University in St. Louis

View shared research outputs
Researchain Logo
Decentralizing Knowledge